2026-2030年全球輔助生殖技術（ART）市場

全球輔助生殖技術（ART）市場預計在 2025 年至 2030 年間成長至 78.856 億美元，預測期內複合年成長率為 5.0%。

本報告對全球輔助生殖技術 (ART) 市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括全球不孕症盛行率上升、胚胎學技術進步、生育年齡延遲以及人口結構變化。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，未來幾年，生育診所基礎設施的擴建將是全球輔助生殖技術（ART）市場成長的主要驅動力之一。此外，人工智慧的日益普及和冷凍細胞庫的擴張預計也將帶來顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球輔助生殖技術（ART）市場
• 基於應用領域的細分市場分析，2020-2024 年
• 按類型分類的細分市場分析，2020-2024 年
• 產品細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球輔助生殖技術（ART）市場
• 地緣政治衝突對全球輔助生殖科技（ART）市場的影響。

第7章：五力分析

第8章 市場區隔：依應用領域

• 比較：透過應用
• 不孕症治療診所
• 醫院
• 其他
• 市場機會：依應用領域分類

第9章 市場細分：依類型

• 比較：按類型
• 體外受精（IVF）
• 人工授精
• 市場機會：按類型分類

第10章 市場區隔：依產品

• 比較：按產品
• 配件
• 設備/器材
• 培養基
• 市場機會：依產品分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷蘭
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 南非
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• ASTEC CO. Ltd.
• BIOPSYBELL Srl
• CooperSurgical Inc.
• Cryo Bio System
• Esco Lifesciences
• Ferring BV
• FertiPro NV
• Genea Biomedx
• Hamilton Thorne Inc.
• Labotect Labor Technik Gottingen
• Merck KGaA
• Microptic SL
• Nexpring Health
• Thermo Fisher Scientific Inc.
• Vitrolife Sweden AB

第16章附錄

The global assisted reproductive technology (ART) market is forecasted to grow by USD 7885.6 mn during 2025-2030, accelerating at a CAGR of 5.0% during the forecast period. The report on the global assisted reproductive technology (ART) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global infertility prevalence, technological advancements in embryology, delayed childbirth and demographics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global assisted reproductive technology (ART) market is segmented as below:

By Application

• Fertility clinics
• Hospitals
• Others

By Type

• IVF
• Artificial insemination

By Product

• Accessories
• Equipment/instruments
• Culture media

Geography

• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• North America
  • US
  • Canada
  • Mexico
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of fertility clinic infrastructure as one of the prime reasons driving the global assisted reproductive technology (art) market growth during the next few years. Also, proliferation of ai integration and expansion of frozen gamete banking will lead to sizable demand in the market.

The report on the global assisted reproductive technology (art) market covers the following areas:

• Global assisted reproductive technology (art) market sizing
• Global assisted reproductive technology (art) market forecast
• Global assisted reproductive technology (art) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global assisted reproductive technology (art) market vendors that include ASTEC CO. Ltd., BIOPSYBELL Srl, CooperSurgical Inc., Cryo Bio System, Esco Lifesciences, Ferring BV, FertiPro NV, Genea Biomedx, Hamilton Thorne Inc., Labotect Labor Technik Gottingen, Merck KGaA, Microptic S.L., Nexpring Health, NidaCon International AB, Planer Ltd., Rocket Medical Plc, SPARMED ApS, Sperm Processor Pvt. Ltd., Thermo Fisher Scientific Inc., Vitrolife Sweden AB. Also, the global assisted reproductive technology (art) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Assisted Reproductive Technology (ART) Market 2020 - 2024
  • Historic Market Size - Data Table on Global Assisted Reproductive Technology (ART) Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Assisted Reproductive Technology (ART) Market
• 6.2 Impact of geopolitical conflicts on Global Assisted Reproductive Technology (ART) Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Fertility clinics - Market size and forecast 2025-2030
• 8.4 Hospitals - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 IVF - Market size and forecast 2025-2030
• 9.4 Artificial insemination - Market size and forecast 2025-2030
• 9.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Accessories - Market size and forecast 2025-2030
• 10.4 Equipment/instruments - Market size and forecast 2025-2030
• 10.5 Culture media - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 Europe - Market size and forecast 2025-2030
  • 12.3.1 Germany - Market size and forecast 2025-2030
  • 12.3.2 France - Market size and forecast 2025-2030
  • 12.3.3 UK - Market size and forecast 2025-2030
  • 12.3.4 Italy - Market size and forecast 2025-2030
  • 12.3.5 Spain - Market size and forecast 2025-2030
  • 12.3.6 The Netherlands - Market size and forecast 2025-2030
• 12.4 North America - Market size and forecast 2025-2030
  • 12.4.1 US - Market size and forecast 2025-2030
  • 12.4.2 Canada - Market size and forecast 2025-2030
  • 12.4.3 Mexico - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global infertility prevalence
  • Technological advancements in embryology
  • Delayed childbirth and demographics
• 13.2 Market challenges
  • High financial burden and costs
  • Regulatory divergence and ethical complexities
  • Severe infrastructure and technical constraints
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of fertility clinic infrastructure
  • Proliferation of AI integration
  • Expansion of frozen gamete banking

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 ASTEC CO. Ltd.
  • ASTEC CO. Ltd. - Overview
  • ASTEC CO. Ltd. - Product / Service
  • ASTEC CO. Ltd. - Key offerings
  • SWOT
• 15.5 BIOPSYBELL Srl
  • BIOPSYBELL Srl - Overview
  • BIOPSYBELL Srl - Product / Service
  • BIOPSYBELL Srl - Key offerings
  • SWOT
• 15.6 CooperSurgical Inc.
  • CooperSurgical Inc. - Overview
  • CooperSurgical Inc. - Product / Service
  • CooperSurgical Inc. - Key offerings
  • SWOT
• 15.7 Cryo Bio System
  • Cryo Bio System - Overview
  • Cryo Bio System - Product / Service
  • Cryo Bio System - Key offerings
  • SWOT
• 15.8 Esco Lifesciences
  • Esco Lifesciences - Overview
  • Esco Lifesciences - Product / Service
  • Esco Lifesciences - Key offerings
  • SWOT
• 15.9 Ferring BV
  • Ferring BV - Overview
  • Ferring BV - Product / Service
  • Ferring BV - Key offerings
  • SWOT
• 15.10 FertiPro NV
  • FertiPro NV - Overview
  • FertiPro NV - Product / Service
  • FertiPro NV - Key offerings
  • SWOT
• 15.11 Genea Biomedx
  • Genea Biomedx - Overview
  • Genea Biomedx - Product / Service
  • Genea Biomedx - Key offerings
  • SWOT
• 15.12 Hamilton Thorne Inc.
  • Hamilton Thorne Inc. - Overview
  • Hamilton Thorne Inc. - Product / Service
  • Hamilton Thorne Inc. - Key offerings
  • SWOT
• 15.13 Labotect Labor Technik Gottingen
  • Labotect Labor Technik Gottingen - Overview
  • Labotect Labor Technik Gottingen - Product / Service
  • Labotect Labor Technik Gottingen - Key offerings
  • SWOT
• 15.14 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.15 Microptic S.L.
  • Microptic S.L. - Overview
  • Microptic S.L. - Product / Service
  • Microptic S.L. - Key offerings
  • SWOT
• 15.16 Nexpring Health
  • Nexpring Health - Overview
  • Nexpring Health - Product / Service
  • Nexpring Health - Key offerings
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Vitrolife Sweden AB
  • Vitrolife Sweden AB - Overview
  • Vitrolife Sweden AB - Product / Service
  • Vitrolife Sweden AB - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations